Nodexus Inc. news

Nodexus was selected as an invited exhibitor at the American Diabetes Association HealthTech Showcase in November 2020.

Nodexus was awarded a NOSI grant for the development of an urgently needed COVID-19 diagnostic platform leveraging the core Nodexus technology suite.

Our entire team’s thoughts are with the families of everyone who has been affected by the COVID-19 pandemic.  We salute the effort of healthcare professionals, public/private institutions, and governments the world over to hopefully bring a speedy resolution to these unprecedented times.

Nodexus was selected for an SBIR grant for the development of a novel cancer stem cell detection and isolation platform leveraging the core Nodexus technology suite.